Course Overview
HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is increasing in prevalence at a rapid pace worldwide. Traditional treatment regimens designed for non-related HPV OPSCC may not apply with this different, and new disease. This international course was created to review the changing trends in the treatment of HPV-related OPSCC, emphasizing minimally invasive transoral surgical approaches. With a strong practical focus, the course will include surgical and medical oriented lectures. Ten hours of cadaver dissection using both a transoral laser microscopic (TLM) technique and transoral robotic surgery (TORS) technique is available with hands-on faculty instruction. International faculty will lead clinical case discussions that will consolidate the learning objectives. The face-to-face relationship between the faculty and participants makes this course an important starting point for all specialists who want to explore minimally invasive transoral surgery for HPV-related OPSCC.
Objectives:
- Indicate the factors that influenced the development of a new staging system for HPV-related oropharyngeal squamous cell carcinoma.
- Describe the impact of traditional risk factors for mortality from HPV-related oropharyngeal squamous cell carcinoma.
- Employ the various transoral surgical procedures utilized for the treatment of HPV-related oropharyngeal squamous cell carcinoma.
- Identify the patient best served with adjuvant treatment following surgery for HPV-related oropharyngeal squamous cell carcinoma.
- Discuss the complications associated with following treatment for HPV-related oropharyngeal squamous cell carcinoma.
Registration Prices:
- Didactic Plus Hands-On Lab: $2,600 (Limited to 16 participants)
- Didactic and Lab Shadow ONLY - $899 (Limited to 16 participants)
- Didactic ONLY- $699 (Limited to 32 participants)
- Resident/Fellow Didactic Plus Lab Shadow: $500
- *All Residents/Fellows must have a letter from Program Director
Accreditation
AdventHealth is accredited by the Florida Medical Association (FMA) to provide continuing medical education for physicians. AdventHealth designates this educational activity for a maximum of 22.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Course Jointly Presented By:
Faculty
Scott Magnuson, MD (USA)
Course Director
Chief Medical Officer
AdventHealth Nicholson Center
Director, Head & Neck Surgery
AdventHealth Celebration Health
Celebration, FL
Michael Hinni, MD (USA)
Course Director
Chair, Department of Otolaryngology -
Head & Neck Surgery
Professor of Otolaryngology
Mayo Clinic College of Medicine
Bruce Haughey, MBChB, FRACS, FACS (USA)
Course Director
Medical Director, Oncology
AdventHealth Celebration
Celebration, FL
Eric Moore, MD (USA)
Professor Otolaryngology-Head and Neck Surgery Mayo Clinic Rochester
Fellowship Director- Head and Neck Surgery Mayo Clinic-Rochester
Rochester, NY
Ryan Jackson, MD (USA)
Assistant Professor
Head and Neck Oncology and Microvascular Reconstructive Surgery
Department of Otolaryngology – Head and Neck Surgery
Washington University School of Medicine
St. Louis, MO
Harry Quon, MD, MS(CRM) (USA)
Co-Director, Multidisciplinary Head and Neck Program
Associate Professor
Department of Radiation Oncology and Molecular Radiation Sciences
Department of Otorhinolaryngology – Head and Neck Surgery
Department of Oncology
Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
Katharine Price, MD (USA)
Assistant Professor of Oncology
Co-Chair, Head and Neck Cancer Disease Group
Mayo Clinic
Rochester, MN
Tarek Mekhail, MD, MSc, FRCSI, FRCSEd (USA)
President, Cancer Institute of Florida
Associate Director, AdventHealth Cancer Institute
Medical Director, Thoracic Cancer Program
Associate Professor – University of Central Florida
Orlando, FL
Fawaz Makki MD, MSc, FRCS(C) (Canada )
Otolaryngology-Head & Neck Surgery
Alberta Health Services
Calgary, Canada
Julia Crawford, BSc, MBBS, FRACS (Australia)
Otolaryngology, Head and Neck Surgeon
St Vincent’s Hospital Sydney
Sydney, Australia
Se Heon Kim, MD (Korea )
Yonsei University
Seoul, South Korea
Ichiro Tateya, MD, PhD (Japan)
Associate Professor
Department of Otolaryngology-Head & Neck Surgery
Graduate School of Medicine
Kyoto University
Kyoto, Japan
Luiz Paulo Kowalski, MD, PhD (Brazil)
Director, Head and Neck Surgery and Otorhinolaryngology Department, A C Camargo Cancer Center, Sao Paulo, Brazil
Terry Jones BSc, FRCSEd, FRCS (ORL-HNS), MD, SFHEA, FASE(RCS), FAcadTM (United Kingdom)
Professor of Head and Neck Surgery
Editor-in-Chief,
Clinical Otolaryngology
NWCR Centre - University of Liverpool
Department of Molecular and Clinical Cancer
Medicine University of Liverpool
Liverpool, UK
Samir Patel, MD (USA)
Consultant, Department of Radiation Oncology
Assistant Professor of Radiation Oncology
Mayo Clinic
Scottsdale, AZ
Surender Dabas, MS, DNB (Surgical Oncology) (India )
Director Surgical Oncology
Director Robotic Surgery
BLK Cancer Center
BL Kapoor Super-speciality Hospital, Delhi
New Delhi, India
Asim Aijaz, MD (USA)
Orlando, Florida
